Logo image of ALPHA.PA

Pharnext (ALPHA.PA) Stock Price, Quote, News and Overview

EPA:ALPHA - Euronext Paris - Matif - FR001400N1P4 - Common Stock - Currency: EUR

0.0002  +0 (+100%)

ALPHA.PA Quote, Performance and Key Statistics

Pharnext

EPA:ALPHA (8/26/2024, 7:00:00 PM)

0.0002

+0 (+100%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High17006
52 Week Low0
Market Cap1.19K
Shares5.95M
Float0
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-18 2016-07-18


ALPHA.PA short term performance overview.The bars show the price performance of ALPHA.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 -50

ALPHA.PA long term performance overview.The bars show the price performance of ALPHA.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALPHA.PA is 0.0002 EUR. In the past month the price decreased by -33.33%. In the past year, price decreased by -100%.

Pharnext / ALPHA Daily stock chart

ALPHA.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.25 290.75B
AMG.DE AMGEN INC 13.94 136.71B
1AMGN.MI AMGEN INC 14.47 135.46B
1GILD.MI GILEAD SCIENCES INC 14.1 119.24B
GIS.DE GILEAD SCIENCES INC 14.07 118.98B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 101.05B
ARGX.BR ARGENX SE 107.45 30.84B
22UA.DE BIONTECH SE-ADR N/A 23.81B
IDP.DE BIOGEN INC 8.38 17.08B
1MRNA.MI MODERNA INC N/A 9.44B
0QF.DE MODERNA INC N/A 9.31B
BIO.DE BIOTEST AG N/A 1.69B

About ALPHA.PA

Company Profile

ALPHA logo image Pharnext SA develops and manufactures drugs for neurological diseases. The company is headquartered in Suresnes, Ile-De-France. The company went IPO on 2016-07-18. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.

Company Info

Pharnext

14 rue de la Republique

Suresnes ILE-DE-FRANCE FR

Employees: 0

ALPHA Company Website

Phone: 33141092230

Pharnext / ALPHA.PA FAQ

What is the stock price of Pharnext today?

The current stock price of ALPHA.PA is 0.0002 EUR. The price increased by 100% in the last trading session.


What is the ticker symbol for Pharnext stock?

The exchange symbol of Pharnext is ALPHA and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALPHA.PA stock listed?

ALPHA.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for Pharnext stock?

9 analysts have analysed ALPHA.PA and the average price target is 12750 EUR. This implies a price increase of 6374999900% is expected in the next year compared to the current price of 0.0002. Check the Pharnext stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is Pharnext worth?

Pharnext (ALPHA.PA) has a market capitalization of 1.19K EUR. This makes ALPHA.PA a Nano Cap stock.


How many employees does Pharnext have?

Pharnext (ALPHA.PA) currently has 0 employees.


Is Pharnext (ALPHA.PA) expected to grow?

The Revenue of Pharnext (ALPHA.PA) is expected to decline by -22.9% in the next year. Check the estimates tab for more information on the ALPHA.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Pharnext (ALPHA.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Pharnext (ALPHA.PA) stock pay dividends?

ALPHA.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of Pharnext (ALPHA.PA)?

Pharnext (ALPHA.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-26278826.88).


ALPHA.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALPHA.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALPHA.PA. ALPHA.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALPHA.PA Financial Highlights

Over the last trailing twelve months ALPHA.PA reported a non-GAAP Earnings per Share(EPS) of -26278826.88. The EPS increased by 99.99% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -627.44%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%N/A
EPS 1Y (TTM)99.99%
Revenue 1Y (TTM)-99.34%

ALPHA.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to ALPHA.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 99.81% and a revenue growth -22.9% for ALPHA.PA


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price Target12750 (6374999900%)
EPS Next Y99.81%
Revenue Next Year-22.9%